Oncompass Medicine

Oncompass Medicine

Budapest, Hungary· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Oncompass Medicine is a Budapest-based precision oncology company leveraging artificial intelligence to interpret complex genomic data and recommend personalized cancer treatments. Its flagship offering is a comprehensive Precision Oncology Program, which includes consultation, molecular diagnostics planning, and treatment selection powered by its proprietary Genomate AI software. The company has established key European partnerships with diagnostic and data firms and has been recognized as a 'Future Unicorn,' positioning it at the intersection of AI, diagnostics, and clinical decision support in oncology.

Oncology

Technology Platform

Genomate AI: A proprietary medical AI software system that analyzes tumor genomic data against a knowledge base of compounds, mutations, and clinical evidence to recommend personalized targeted therapy options for cancer patients.

Opportunities

The rapid growth of targeted therapies and NGS testing creates a massive need for AI-driven interpretation to guide treatment decisions.
Expansion through partnerships with major European hospital consortia provides a direct path to scale its service model and integrate into standard care pathways.

Risk Factors

Clinical adoption risk requires robust validation to convince oncologists.
Regulatory hurdles (CE/FDA) and securing reimbursement from healthcare payers are critical challenges.
The competitive landscape for oncology AI is intensifying rapidly.

Competitive Landscape

Oncompass competes in the growing market of AI-powered clinical decision support (CDS) in oncology, facing competition from pure-play AI startups (e.g., Tempus, Paige.AI outside Europe), large diagnostic companies integrating AI, and electronic health record vendors. Its differentiation lies in its integrated service program and strong European partnership network.